Factor associated with OS in patients with unresectable HCC treated with atezolizumab/bevacizumab or lenvatinib after propensity-score matching.
收藏Figshare2025-12-18 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/_p_Factor_associated_with_OS_in_patients_with_unresectable_HCC_treated_with_atezolizumab_bevacizumab_or_lenvatinib_after_propensity-score_matching_p_/30914408
下载链接
链接失效反馈官方服务：
资源简介：
Factor associated with OS in patients with unresectable HCC treated with atezolizumab/bevacizumab or lenvatinib after propensity-score matching.
创建时间：
2025-12-18
